Search Form
First, enter a politician or zip code
Now, choose a category
 

Patrick Leahy's Public Statements on Issue: Health and Health Care

Office: U.S. Senate (VT) - Sr, Democratic
Date Title
May 4, 2017 Vermont Awarded $2 Million Federal Grant to Address Opioid Misuse
May 2, 2017 Letter to the President - Reverse Course on Anti-Women's Agenda
March 30, 2017 Leahy Slams The Latest Republican-Led Rule Rollback, Which Threatens Women's Access To Health Care, Especially In Rural Areas
March 29, 2017 Letter to the Honorable Donald J. Trump, President of the United States - Abandon ACA Repeal Efforts
March 24, 2017 Reaction Of Senator Patrick Leahy To Withdrawal Of The Trumpcare Bill From The House Floor
March 21, 2017 Letter to the Hon. Mich McConnell - Regarding Opioid Crisis
March 7, 2017 Comment Of Senator Patrick Leahy On Congressional Republicans' Trumpcare Plan
March 1, 2017 Letter to the Hon. Mitch McConnell - Drop Republican Efforts to Gut Family Planning Centers
Feb. 16, 2017 Leahy Opposes Nomination Of Mick Mulvaney To Be OMB Director
Feb. 8, 2017 Letter to Mr. Spencer Williamson, President and Chief Executive Officer of Kaléo Pharmaceuticals - Concern That Kaléo Dramatically Increased the Cost of its Naloxone Injector Device
Jan. 25, 2017 Letter to President Trump - Exempt Entire VA from Hiring Freeze
Jan. 6, 2017 Ranking Member Leahy Statement on Reports That PEOTUS Trump Will Ask Congress to Pay for Border Wall
Jan. 5, 2017 As New Congress Opens, Leahy Joins Klobuchar And Others To Introduce Legislation To Lower Prescription Drug Prices For Seniors
Dec. 22, 2016 Letter to the Hon. Donald Trump - Regarding Protection of Family Planning Centers
Dec. 20, 2016 Letter to President-elect Trump - Take Action in Bringing Down Prescription Drug Prices
Dec. 14, 2016 Letter to the Hon. Sylvia Mathews Burwell, Department of Health and Human Services Secretary - Applauding the Final Rule Protecting Title X Health Care Providers
Dec. 9, 2016 Energy and Water Development and Related Agencies Appropriations Act, 2016
Dec. 7, 2016 Tsunami Warning, Education, and Research Act of 2015
Dec. 6, 2016 Under Leahy's Initiative, Bipartisan Leaders Of The Senate Judiciary Committee Urge Senators To Address Rising Prescription Drug Prices
Nov. 16, 2016 Leahy To Serve As Vice Chairman Of Senate Appropriations Committee
Nov. 7, 2016 Letter to the Honorable Edith Ramirez, Chairwoman of the Federal Trade Commission - Regarding Mylan's Engagement in Potential Anti-Competitive Practices
Nov. 1, 2016 Letter to Ms. Heather Bresch, CEO, Mylan - New Questions for Mylan About EpiPen Price Hike, Pricing Strategy
Oct. 26, 2016 Letter to the Honorable Loretta E. Lynch, Attorney General of the United States - Leahy Presses Administration to Take On Opioid Distributors
Oct. 11, 2016 Letter to the Hon. Samantha Power, Permanent U.S. Representative to the United Nations - Clarify Position on Cholera Epidemic in Haiti
Oct. 7, 2016 Letter to the Hon. Sylvia Mathews Burwell, Secretary of the Department of Health and Human Services - Compliance with Title X Requirements to Project Recipients in Selecting Subrecipients
Sept. 28, 2016 Leahy Praises Administration's Rule, Issued Tonight, To End Forced Arbitration In Long-Term Care Facilities
Sept. 20, 2016 Letter to the Honorable Sylvia Burwell, Secretary of the Dept. of Health and Human Services - Senators Push to Protect Women's Access to Contraceptive Coverage
Sept. 20, 2016 Letter to the Hon. Ban Ki-moon, Secretary-General of the United Nations - Regarding the UN's Obligation to Aid in the Haitian Cholera Epidemic
Sept. 14, 2016 The Future of the VA: Examining the Commission on Care Report and VA's Response
Sept. 14, 2016 Senators Introduce Legislation to Overhaul Veterans Appeals Process
Sept. 9, 2016 Schatz, Nelzon, Leahy, other Senators Press Speaker Ryan for vote on Zika funding
Sept. 9, 2016 Letter to the Hon. Paul Ryan, Speaker of the House - Vote on Zika Funding
Aug. 31, 2016 Leahy, Sanders Join Other Senators In Raising Concerns About Mylan's EpiPen Price Hike And Expanded Patient Assistance Program
Aug. 30, 2016 Letter to Ms. Heather Bresch, Chief Executive Officer of Mylan - Concerns About Mylan's EpiPen Price HIke
Aug. 24, 2016 Letter to Dr. Robert M. Califf, Commissioner of the Food and Drug Administration - Account for Any Alternatives to the EpiPen Amid Product Cost Increase
Aug. 4, 2016 Letter to Honorable Mitch McConnell, Majority Leader of the U.S. Senate, and the Honorable Paul Ryan, Speaker of the U.S. House of Representatives - Senate Democrats Urge Congress to Return to Fight Zika
July 23, 2016 Two Bills Championed By Leahy Signed Into Law
July 18, 2016 Letter to Mr. Andrew M. Slavitt, Acting Administrator of the Centers for Medicare & Medicaid Services - Update Lead Screening Policy to Protect Children
July 15, 2016 Letter to Andrew Slavitt, Acting Administrator of the Centers for Medicare-and Medicaid Services - Update Current Lead Screening Policy to Protect Children from Lead Hazards, Prevent Life-Long Health Effects
July 14, 2016 Letter to Mitch McConnell, Majority Leader of the United States Senate - As Congress Clears Comprehensive Addiction and Recovery Bill, Reed Calls for Emergency Funding for Opioid Epidemic
July 13, 2016 Letter to The Honorable Mitch McConnell. Majority Leader, United States Senate - Commit to Passing Real, Immediate Funding to Fight Opioid and Heroin Epidemic and Actually Carry Out Programs Authorized in CARA Bill
July 13, 2016 Statement of Senator Patrick Leahy On Cloture Vote of S.524, the Comprehensive Addiction And Recovery Act
July 13, 2016 Senate Wednesday Night Passes Bill Cosponsored By Leahy To Target Opioid And Heroin Abuse
July 13, 2016 Federal Aviation Administration Reauthorization Act of 2016--Continued
July 5, 2016 Letter to the Honorable Fred Upton, Chairman of the Committee on Energy and Commerce - Refusal to Sign Opioid Conference Report Without Funding to Combat Drug Addiction Epidemic
June 27, 2016 Statement of Senator Patrick Leahy On the Supreme Court, Emergency Funding for Zika, and Judicial Nominations
June 21, 2016 Hearing of the Senate Judiciary Committee - Opening Statement of Sen. Leahy, Hearing on the CREATES Act: Ending Regulatory Abuse, Protecting Consumers, and Ensuring Drug Price Competition
June 21, 2016 Hearing of the Antitrust, Competition Policy and Consumer Rights Subcommittee of the Senate Judiciary Committee - "The CREATES Act: Ending Regulatory Abuse, Protecting Consumers, and Ensuring Drug Price Competition"
June 21, 2016 Letter to Robert Califf, MD, Commissioner, U.S. Food and Drug Administration - End Discriminatory Blood Donation Ban
June 21, 2016 At SJC Hearing On Rising Prescription Drug Prices, Leahy Calls For Congressional Action
Skip to top

Help us stay free for all your Fellow Americans

Just $5 from everyone reading this would do it.

Back to top